James C. Blair, Director, 10% Owner at CADENCE PHARMACEUTICALS INC (CADX), sold 66 shares at $5.01 ($331) on 2013-02-20, disclosed to the SEC on 2013-02-22.
Scheduled sale ($331) by Director, 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| BNGO | BUY | 2018-08-27 | $92K | — | Filing → |
| CLVS | SELL | 2017-08-08 | $2.9M | — | Filing → |
| EVOK | SELL | 2016-05-27 | $1.6M | — | Filing → |